Unknown

Dataset Information

0

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment.


ABSTRACT: While remdesivir has garnered much hope for its moderate anti-Covid-19 effects, its parent nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir evidences premature serum hydrolysis to GS-441524; GS-441524 is the predominant metabolite reaching the lungs. With its synthetic simplicity and in vivo efficacy in the veterinary setting, we contend that GS-441524 is superior to remdesivir for Covid-19 treatment.

SUBMITTER: Yan VC 

PROVIDER: S-EPMC7315846 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8571282 | biostudies-literature
| S-EPMC8366795 | biostudies-literature
| S-EPMC7337789 | biostudies-literature
| S-EPMC8612139 | biostudies-literature
| S-EPMC8646568 | biostudies-literature
| S-EPMC7125341 | biostudies-literature
| S-EPMC7118644 | biostudies-literature
| S-EPMC10326674 | biostudies-literature
| S-EPMC7875336 | biostudies-literature
| S-EPMC6435921 | biostudies-literature